Evidence map›Paper›PMID 36207710›Full record

ArticleBMC health services research2022

Rationale and guidance for strengthening infection prevention and control measures and antimicrobial stewardship programs in Bangladesh: a study protocol.

Md Golam Dostogir Harun, Md Mahabub Ul Anwar, Shariful Amin Sumon, Md Zakiul Hassan, Tahrima Mohsin Mohona, Aninda Rahman, Syed Abul Hassan Md Abdullah, Md Saiful Islam, S Cornelia Kaydos-Daniels, Ashley R Styczynski

Abstract read
In one paragraph

Article in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Mobile Colistin-Resistant GenesAntibiotics (Basel, Switzerland) · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Does Emerging Carbapenem Resistance inInfectious disease reports · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Md Golam Dostogir HarunProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka, Bangladesh. dostogirharun@icddrb.org.ORCID http://orcid.org/0000-0002-7884-740X
Md Mahabub Ul AnwarCenters for Disease Control and Prevention (CDC), Bangladesh Country Office, Dhaka, Bangladesh.
Shariful Amin SumonProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka, Bangladesh.
Md Zakiul HassanProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka, Bangladesh.
Tahrima Mohsin MohonaProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka, Bangladesh.
Aninda RahmanCommunicable Disease Control, Directorate General of Health Services, Dhaka, Bangladesh.
Syed Abul Hassan Md AbdullahSafetyNet, Dhaka, Bangladesh.
Md Saiful IslamUniversity of New South Wales, Sydney, Australia.
S Cornelia Kaydos-DanielsCenters for Disease Control and Prevention (CDC), Bangladesh Country Office, Dhaka, Bangladesh.
Ashley R StyczynskiDivision of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, USA.

Funding

Global Epidemiology of Infectious DiseasesT32AI052073 · NIAID · STANFORD UNIVERSITY · PI Angelle Desiree LaBeaud, Stephen Patrick Luby · 2003 to 2026
$4.2M
CDC HHS Award# 6NU51GH001209CGH CDC HHS U51 GH001209NIAID NIH HHS T32 AI052073
6 · The paper itself

Abstract

backgroundHospital-acquired infections (HAIs) and antimicrobial resistance (AMR) are major global health challenges. Drug-resistant infectious diseases continue to rise in developing countries, driven by shortfalls in infection control measures, antibiotic misuse, and scarcity of reliable diagnostics. These escalating global challenges have highlighted the importance of strengthening fundamental infection prevention and control (IPC) measures and implementing effective antimicrobial stewardship programs (ASP). This study aims to present a framework for enhancing IPC measures and ASP efforts to reduce the HAI and AMR burden in Bangladesh.

methodsThis implementation approach will employ a mixed-methods strategy, combining both quantitative and qualitative data from 12 tertiary hospitals in Bangladesh. A baseline assessment will be conducted using the Infection Prevention and Control Assessment Framework (IPCAF) developed by the WHO. We will record IPC practices through direct observations of hand hygiene, personal protective equipment (PPE) utilization, and hospital ward IPC infrastructure. Additionally, data on healthcare providers' knowledge, attitudes, and practices regarding IPC and antibiotic prescribing will be collected using both structured questionnaires and qualitative interviews. We will also assist the hospital leadership with establishing and/or strengthening IPC and ASP committees. Based on baseline assessments of each healthcare facility, tailored interventions and quality improvement projects will be designed and implemented. An end-line assessment will also be conducted after 12 months of intervention using the same assessment tools. The findings will be compared with the baseline to determine changes in IPC and antibiotic stewardship practices. DISCUSSION: Comprehensive assessments of healthcare facilities in low-resource settings are crucial for strengthening IPC measures and ASP activities,. This approach to assessing existing IPC and ASP activities will provide policy-relevant data for addressing current shortfalls. Moreover, this framework proposes identifying institutionally-tailored solutions, which will ensure that response activities are appropriately contextualized, aligned with stakeholder priorities, and offer sustainable solutions.

conclusionFindings from this study can guide the design and implementation of feasible and sustainable interventions in resource-constrained healthcare settings to address gaps in existing IPC and ASP activities. Therefore, this protocol will be applicable across a broad range of settings to improve IPC and ASP and reduce the burden of hospital-acquired infections and AMR.

Indexed as

Antimicrobial StewardshipCross InfectionAnti-Bacterial AgentsBangladeshHumansInfection ControlAnti-Bacterial AgentsAntimicrobial resistanceAntimicrobial stewardshipHealthcare quality improvementHospital-acquired infectionsInfection prevention and controlTertiary hospital

Identifiers

PMID36207710
PMCPMC9540083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.